T-cell Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) [Phase 1]
Phase 1 trial updating the addition of lenalidomide to the EPOCH chemotherapy regimen for adult T-cell leukemia/lymphoma; the study is curre…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
The document provides an update on a study assessing clinico-biological features and survival in adults with HTLV-1–associated adult T-cell …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma [Phase 2]
Phase 2 trial evaluating belinostat in combination with zidovudine for adult T-cell leukemia/lymphoma has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma [Phase 1, Phase 2]
Phase I/II study of ASTX660 in relapsed or refractory T-cell lymphomas has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) [Phase 2]
This Phase II study evaluates single-agent Brentuximab Vedotin in relapsed/refractory CD30-low mature T-cell lymphomas; the trial has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
The document reports a completed clinical trial evaluating lenalidomide (Revlimid) for relapsed or refractory adult T-cell leukemia/lymphoma…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial results for BV-CHEP chemotherapy in adults with adult T-cell leukemia/lymphoma and lymphoma have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma [Phase 2]
Valemetostat tosylate (DS-3201b) Phase 2 study in relapsed or refractory Adult T-cell Leukemia/Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) [Phase 2]
Phase 2 trial evaluating oral HBI-8000 in relapsed or refractory adult T-cell leukemia/lymphoma reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) [Phase 2]
Daiichi Sankyo reported an update on valemetostat tosylate (DS-3201b), an EZH1/2 dual inhibitor, in a Phase 2 trial (VALENTINE-PTCL01) for r…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in combination chemotherapy for CD30-positive peripheral T-cell lymphomas reports results poste…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome [Phase 1]
Phase I trial evaluating recombinant human IL-15 in combination with mogamulizumab for refractory/relapsed adult T-cell leukemia/lymphoma an…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma [Phase 2]
Phase 2 trial of nivolumab in HTLV-1–associated adult T-cell leukemia/lymphoma has completed and results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) [Phase 2]
Phase 2 trial update on KW-0761 (mogamulizumab) in adults with previously treated Adult T-cell Leukemia-Lymphoma; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
This entry notes the completed status of a clinical trial studying adult T-cell leukemia/lymphoma in carriers of HTLV-1.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
This completed NCI-supported trial examined familial and genetic factors in HTLV-1–related diseases, including adult T-cell leukemia/lymphom…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Dual Algorithm Post Market Clinical Study
Post-market clinical study update for MP Biomedicals' Dual Algorithm evaluating its use in HTLV-I and HTLV-II infections and related HTLV-1 …
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 [Phase 2]
This clinical trial update reports completion of a multicenter, randomized Phase 2 study comparing mLSG15 plus KW-0761 (mogamulizumab) versu…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated the combination of EPOCH chemotherapy and bortezomib in adults with adult T-cell leukemia/lym…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) [Phase 3]
A Phase 3 study evaluating treatment for aggressive Adult T-cell leukemia/lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Lenalidomide in HTLV-1 Adult T-Cell Leukemia [Phase 2]
This report notes the completion of a Phase 2 trial evaluating lenalidomide in adults with HTLV-1–associated adult T-cell leukemia/lymphoma,…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial sponsored by the National Cancer Institute evaluated alisertib for relapsed or refractory peripheral T-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma [Phase 2]
This Phase 2 clinical trial evaluates a sequence of chemotherapy followed by antiviral therapy and interferon alfa in patients with HTLV-1-r…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma [Phase 2]
A Phase 2 trial evaluated lenalidomide in patients with relapsed or recurrent Adult T-cell leukemia/lymphoma. The study has completed and re…